Double-Action Antibiotic Advances In GSK's Pipeline

Dosing Starts In Phase III Gepotidacin Studies

 
• By John Davis
  
Eagle
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapy Areas